Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma
Open Access
- 15 May 1998
- Vol. 82 (10), 1946-1951
- https://doi.org/10.1002/(sici)1097-0142(19980515)82:10<1946::aid-cncr19>3.0.co;2-t
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Primary central nervous system non-hodgkin's lymphoma: Survival advantages with combined initial therapy?International Journal of Radiation Oncology*Biology*Physics, 1995
- Treatment of primary central nervous system lymphoma: still more questions than answers [editorial; comment]Blood, 1995
- The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression [see comments]Blood, 1995
- Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphomaNeurology, 1994
- Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcomeJournal of Neurosurgery, 1994
- Combined modality therapy for primary CNS lymphoma.Journal of Clinical Oncology, 1992
- Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315International Journal of Radiation Oncology*Biology*Physics, 1992
- Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.Journal of Clinical Oncology, 1991
- High-dose methotrexate for non-AIDS primary central nervous system lymphomaJournal of Neurosurgery, 1989
- Central nervous system involvement in non-Hodgkin's lymphoma: An analysis of 105 casesCancer, 1982